Perrigo Company PLC (PRGO)
Inventory turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 2,975,200 | 2,996,200 | 2,722,500 | 3,248,100 | 3,064,100 |
Inventory | US$ in thousands | 1,140,900 | 1,150,300 | 1,020,200 | 1,059,400 | 967,300 |
Inventory turnover | 2.61 | 2.60 | 2.67 | 3.07 | 3.17 |
December 31, 2023 calculation
Inventory turnover = Cost of revenue ÷ Inventory
= $2,975,200K ÷ $1,140,900K
= 2.61
The inventory turnover ratio for Perrigo Company plc has shown a decreasing trend over the past five years, declining from 3.17 in 2019 to 2.61 in 2023. This indicates that the company is selling its inventory at a slower rate compared to previous years. A lower inventory turnover ratio may suggest overstocking or inefficient inventory management, potentially leading to higher storage and holding costs. Perrigo should closely monitor its inventory levels and sales to optimize its inventory turnover and enhance operational efficiency.
Peer comparison
Dec 31, 2023
Company name
Symbol
Inventory turnover
Perrigo Company PLC
PRGO
2.61
Abbott Laboratories
ABT
4.78
AbbVie Inc
ABBV
11.08
Alkermes Plc
ALKS
5.28
Amphastar P
AMPH
2.77
ANI Pharmaceuticals Inc
ANIP
3.62
Arcus Biosciences Inc
RCUS
—
Biomarin Pharmaceutical Inc
BMRN
0.47
Bristol-Myers Squibb Company
BMY
10.53
Catalent Inc
CTLT
5.97
Catalyst Pharmaceuticals Inc
CPRX
13.95